GTS Securities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
GTS Securities's NVS Position: Q2 2026 in Review
GTS Securities opened a new position in Novartis (NVS) in Q2 2026: 3,897 shares worth $611K. The stake represents 0.01% of the portfolio and ranks #628 among its holdings. This is a return to the name: GTS Securities previously reported a position in NVS as recently as Q4 2025.
GTS Securities first reported a position in NVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.6M in Q3 2025. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- GTS Securities held 3,897 shares of Novartis worth $611K as of Q2 2026.
- Novartis was a new GTS Securities position in Q2 2026.
- Novartis made up 0.01% of GTS Securities's portfolio in Q2 2026, its #628 holding.
- GTS Securities first reported a position in Novartis in Q3 2024 and has held it in 7 quarters since.
- GTS Securities's Novartis position peaked at $1.6M in Q3 2025.
- 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.